Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer.
This study investigated the application of an acquisition that selectively excites the [1-13C]lactate resonance and allows dynamic tracking of the conversion of 13C-lactate from hyperpolarized 13C-pyruvate at a high spatial resolution. In order to characterize metabolic processes occurring in a mouse model of prostate cancer, 20 sequential 3D images of 13C-lactate were acquired 5 s apart using a pulse sequence that incorporated a spectral-spatial excitation pulse and a flyback echo-planar readout to track the time course of newly converted 13C-lactate after injection of prepolarized 13C-pyruvate. The maximum lactate signal (MLS), full-width half-maximum (FWHM), time to the peak 13C-lactate signal (TTP) and area under the dynamic curve were calculated from the dynamic images of 10 TRAMP mice and two wild-type controls. The regional variation in 13C-lactate associated with the injected pyruvate was demonstrated by the peak of the 13C-lactate signal occurring earlier in the kidney than in the tumor region. The intensity of the dynamic 13C-lactate curves also varied spatially within the tumor, illustrating the heterogeneity in metabolism that was most prominent in more advanced stages of disease development. The MLS was significantly higher in TRAMP mice that had advanced disease.
Lupo
Janine M
JM
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA 94158, USA. janinel@radiology.ucsf.edu
Chen
Albert P
AP
Zierhut
Matthew L
ML
Bok
Robert A
RA
Cunningham
Charles H
CH
Kurhanewicz
John
J
Vigneron
Daniel B
DB
Nelson
Sarah J
SJ
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D002247:Carbon Isotopes / Q000032:analysis; D003936:Diagnosis, Computer-Assisted / Q000379:methods; D004195:Disease Models, Animal; D006801:Humans; D019344:Lactic Acid / Q000032:analysis*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor; D002247:Carbon Isotopes; D019344:Lactic Acid
Magn Reson Med. 2007 Dec;58(6):1099-106
17969006
Nat Rev Cancer. 2004 Nov;4(11):891-9
15516961
J Magn Reson. 2007 Aug;187(2):357-62
17562376
Cancer Res. 2006 Nov 15;66(22):10855-60
17108122
Magn Reson Med. 2007 Jul;58(1):65-69
17659629
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3439-43
7724580
Prostate. 2003 May 15;55(3):219-37
12692788
Magn Reson Med. 2006 Jun;55(6):1257-64
16685733
J Nucl Med. 2008 Jun;49 Suppl 2:24S-42S
18523064
Cancer Res. 1996 Sep 15;56(18):4096-102
8797572
Magn Reson Med. 2005 Nov;54(5):1286-9
16187273
Cancer Res. 2008 Oct 15;68(20):8607-15
18922937
Eur Radiol. 2006 Jan;16(1):57-67
16402256
Nat Med. 2007 Nov;13(11):1382-7
17965722
J Magn Reson B. 1996;113:179-83
11543610
J Urol. 1993 Dec;150(6):2019-24
7693985
J Magn Reson. 2008 Jul;193(1):139-46
18424203
J Nucl Med. 2008 Mar;49(3):341-4
18322118
Magn Reson Med. 2008 Sep;60(3):510-6
18727052
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10158-63
12930897
Magn Reson Med. 2001 Aug;46(2):228-39
11477625